
Scipher Medicine, a precision immunology company, announced the launch on Scipher Therapeutics on Thursday, marking the company’s shift towards the …

Exscientia and Evotec have announced that they are entering an AI-designed immuno-oncology drug into Phase I trials for the first …

Iktos has announced that its artificial intelligence (AI) technology for de novo design will be applied to selected Pfizer small-molecule …

AstraZeneca and RenalytixAI have agreed a deal to develop joint precision medicine strategies for cardiovascular, renal and metabolic diseases. The …

Biopharma firm AI Therapeutics is partnering with Yale School of Medicine to launch a new clinical trial to identify the efficacy …

A new study published in The Lancet has called on the global health community to establish guidelines to develop and …

MIT researchers have identified a new antibiotic compound using a machine-learning algorithm. In the laboratory tests, the drug killed many …

The FDA have given marketing approval for Caption Health’s Caption Guidance and its use in cardiac ultrasound images.The technology allows …
Clinical trials are one of the longest and most expensive steps of bringing a drug to market. Conor Kavanagh investigates …

Exscientia has created a new OCD drug using artificial intelligence to sift through potential compounds, checking them against a huge …

A recent study showed that Artificial Intelligence is more accurate than doctors in diagnosing breast cancer from mammograms. The research …

Few in the NHS trust ‘big tech’ companies to handle patient data in a confidential manner, a recent YouGov poll …

Charlotte Walker-Osborn, Partner and International Technology Sector Head and Nabil Asaad, Senior Associate, Intellectual Property Law Group – both from …

Through the use of Genomenon’s AI-driven Mastermind Genomic Search Engine, the Rare Genomics Institute succeeded where a leading genetics laboratory …

This week’s top story covered the scandal surrounding Novartis over its covering up of faulty data from the FDA. The …